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EYEBROW

The

Myth

“It’s
All in
Your
Head”

DePaul scientists
work to unravel the
mystery of chronic
fatigue syndrome.
By Abigail Pickus
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CHRONIC FATIGUE

Research scientists Marcie and Mark Zinn view 3D images
to identify the sources of dysregulation in the brain.

I

n 1980, a high school English teacher from Wisconsin named
Pat Fero went on a trip to England. Healthy and in her 30s, she
noticed something was very wrong toward the end of the trip.
“We were in this beautiful countryside, and we went to climb a
hill to get a better view of a lake and I just couldn’t do it. I thought,
I am really out of shape. I couldn’t get up that hill. My legs hurt, and
I was dizzy and short of breath,” recalls Fero.
When she returned home the fever hit.
“I had a 104° fever for a week and a headache from hell. I had
extreme pain in my neck and shoulders that lasted another week,”
she says.
Over the next few years she got progressively sicker until she couldn’t
climb the stairs at school without resting on the landing. Then she
was unable to write on the chalkboard. “I would misspell things. I
couldn’t form the letters correctly. I would miss words. Day-to-day
communication became tough. That’s why I left the classroom. You
can’t be in front of 20-some kids and seriously not know what you’re
talking about,” she says.
In 1988, Fero went on medical leave—and never returned. That
was the year she finally received a diagnosis for her suffering: chronic
fatigue syndrome.

Mystery Disease
Tragically, Fero is not alone. Using research data developed at DePaul,
the Centers for Disease Control and Prevention (CDC) estimates that
there are currently more than 1 million people in the U.S. and more
than 17 million worldwide with chronic fatigue syndrome/myalgic
encephalomyelitis (CFS/ME)—and these are just the ones who have
been diagnosed. (See sidebar: What’s in a Name?)
Often triggered by a virus, this debilitating disease continues to
plague people for years with symptoms that run the gamut from nerve
pain and cognitive impairments to a fatigue better characterized as
bone-crushing exhaustion.
“Don’t use the word fatigue. It’s an exhaustion so severe that you
can’t stand up because you feel like you’re going to faint,” says Fero.
Often lumped together with other so-called “mystery illnesses”
such as Lyme disease and fibromyalgia, CFS/ME is historically
misdiagnosed or underdiagnosed simply because one of its defining
symptoms—fatigue—is both commonplace and seemingly benign.
Adding insult to injury, CFS/ME is notoriously stigmatized because of
its name “chronic fatigue,” suggesting that the patient is merely tired.
But the medical community is baffled, from what causes it to
what it really is: A brain disease? A virus? And with federal funding
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Center for
Community Research
Jason has been at DePaul since 1975. Boyish and slender with round
wire-framed glasses and a friendly manner, he arrived at DePaul
immediately after receiving his PhD from the University of Rochester,
having been drawn initially to DePaul because of its values. In fact, his
area of psychology—clinical community psychology—has distinctly
Vincentian roots with its emphasis on understanding and addressing
social problems, particularly for the underserved. It was in this vein
that Jason founded the Center for Community Research in 2001.
Jason’s initial interest in CFS/ME was personal. In 1989, he was
hit with the disease after coming down with mononucleosis, which
many researchers now feel could be one of the triggers for the illness. It
took him a full year to feel better, and when he did, he started plowing
through the meager literature on the disease. What he discovered was
that he was in a unique position to make a difference. “It just seemed
like there were so many interesting issues with this illness and that I,
as a person who had experienced it myself who was also a psychologist
with a background in strong research methods, could spend a lot of
time making contributions,” he says. He then pursued the matter from
all angles, from correcting what he considered to be an inaccurate case
definition to countering inappropriate CFS/ME myths from some in
the medical community.
“It was evident to me that there was a lot of stigma against people
who had what’s called chronic fatigue syndrome, which is not a
very good term because it is trivializing,” he says. Also trivializing
were the treatments recommended to patients. “Here you have
these exhausted and sick people, and you basically want them to do
exercise and be more active because that’s what you thought would
help them,” he says.

DePaul University/Center for Community Research
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for research into CFS/ME improving but still lower than for other
major diseases, the quality of life for millions of Americans is left
hanging in the balance.
Enter Leonard Jason, a professor of psychology at DePaul, who
with his team has been making serious inroads into cracking the
code on this mystery illness. “DePaul has been trying to validate the
experience of patients with CFS/ME, to find ways to lessen the burden
of this illness by reporting on accurate prevalence numbers among
adults and children, to find effective treatments and to understand
its etiology,” says Jason.
It’s a tall order, but with more than 800 professional publications
and 25 books to his name (many on CFS/ME), plus more than
$36 million in research grants, Jason and the DePaul Center for
Community Research have emerged as leading figures in an area of
medicine otherwise shrouded in darkness.

DePaul Psychology Professor Leonard
Jason is a leading expert on CFS/ME.

An example of a deregulated network in a person with CFS/ME
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“The prevalence rates
were not very accurate
back in the ’90s when
I first started doing
research, and the
methodology used by
the CDC was flawed.”
Leonard Jason

It was Jason’s team who coined the term “staying within the energy
envelope” as a counter to these popular treatments. In numerous papers,
Jason showed that for patients with CFS/ME, pushing too hard leads
to serious consequences known among ME sufferers as post-exertional
malaise, where the body and brain shut down.
One of Jason’s most significant contributions to the field has
been quantifying the number of adults in the U.S. with the disease.
“The prevalence rates were not very accurate back in the ’90s when I
first started doing research, and the methodology used by the CDC
was flawed. At the time, it was considered a rare ‘Yuppie flu’ disease
primarily affecting white middle-class women. As a result of this myth,
the federal government did not provide a lot of resources for those
people who had this illness,” he says.
Throughout the 1990s, Jason and his team conducted a community-based epidemiology prevalence study and came to a staggering
conclusion: Instead of 20,000 Americans with this illness, the number
was probably closer to a million, and it was actually minorities,
particularly Hispanics, who were disproportionately affected by the
disease. The CDC has since updated its figures based on DePaul’s
research and its own subsequent study. While serving on the CDC’s
Chronic Fatigue Syndrome Advisory Committee in the mid-2000s,
Jason was able to make recommendations to the Secretary of U.S.
Health and Human Services about the research and service needs of
this patient group.

Mapping Brainwaves
One sunny, summer afternoon, research scientists Marcie and Mark
Zinn were hard at work in the laboratory they fashioned inside DePaul’s

Center for Community Research to view images created by quantitative
electroencephalography (qEEG) that maps the brain waves of people
with CFS/ME. Pointing to two computer monitors displaying a 3D
cross section of the brain alongside the EEG squiggles tracking the
brain’s metabolic activity, Marcie shows how the technology uses
low-resolution electromagnetic tomography (LORETA) software to
estimate the sources in the brain causing its dysregulation. It does this
all at the millisecond level, the time frame in which the brain actually
operates—a vast improvement over the functional MRI, which has
a 2- to 3-second delay.
“A normally functioning brain depends on the neurons functioning
within a certain time frame. For patients with ME, the neurons are
either damaged or dead, which causes cognitive impairments because
of the slowed speed and the first part of the processing hasn’t been
resolved before they move on to the next,” says Marcie.
qEEG was developed by Clinical Neuroscience Professor Robert
Thatcher, who uses it to examine all types of brain injuries; it is also
used to study the brains of those with autism and traumatic brain
injury. DePaul is the only research center in the world using qEEG
to link communication between neural networks and the cognitive
dysregulation of patients with CFS/ME. This is something the Zinns
hope will change.
“Right now it’s very hard to measure ME, which makes it hard to
diagnose. People either have to go to an infectious diseases doctor or
[we] have to wait until they’re dead for their brains to be autopsied.
“One of the things we’re trying to work on is for doctors to use
our technology in their offices to help potential patients with ME,”
says Marcie, adding that the diagnostic procedures used currently are
only accurate in about 50 percent of the cases.
WINTER 2019
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For Marcie, who also suffers from the disease, focusing on the
brain is a significant step in the right direction particularly because
blood tests cannot detect CFS/ME. “Just because a doctor doesn’t
find any indicators of illness in a person’s blood doesn’t mean they
aren’t sick. It just means they aren’t looking where the problem is,”
says Marcie.

The Invisible Demographic
“I really don’t want to die, but it’s really hard to call this living,” says
CFS/ME patient Jennifer Brea in her chilling documentary, “Unrest,”
which documents just how widespread—and debilitating—the disease
is. Some of the most heart-wrenching stories in the film are about
young people who have spent most of their formative years bedridden.
It turns out that children are the most invisible demographic to be
hit by CFS/ME. Only Jason and his team are putting a number on
this phenomenon. They are currently wrapping up a rigorous study
of 10,000 children to estimate its prevalence among youth.
“Sometimes there are children who are functioning at a very high
level and then all of a sudden something happens—there’s an accident
or there might be some type of virus, we’re still trying to understand
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The Zinns began using qEEG in 2001 to study the brain patterns
of concert pianists, a profession they both pursued before switching to
careers in psychology. They transitioned to studying patients with CFS/
ME in 2010 at Stanford University under Jose Montoya, an infectious
disease doctor, and have continued their work since joining DePaul in
2015. Marcie is the former director of the center’s cognitive systems
neuroscience unit, and Mark is pursuing a PhD in community psychology.
They have studied the brains of more than 200 patients with ME/
CFS and have published many research articles on different aspects
of the disease. Among their discoveries is that post-exertional malaise
is truly all in patients’ heads—just not in the way doctors thought.
“Their brain function literally tanks. We can actually see that,” says
Marcie. They’ve also seen how CFS/ME patients’ everyday waking
brain is drowsy because of too many delta waves.
All these findings have given those suffering from the disease the kind
of validation they have long sought. “To see your brain light up like a
Christmas tree when you do a simple task really validates what I already
know,” says Fero, who came to DePaul to participate in the studies. “I
didn’t think I wasn’t able to write on the chalkboard because there was
some psychiatric problem. I knew there was something wrong with my
brain. These 3D scans confirm that.”

Volunteers with CFS/ME come to DePaul’s Center for Community Research to participate in
studies during which a special cap measures their brain waves, and a software program called
eLORETA links communication between neural networks and cognitive dysregulation.
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What’s in a Name?

Instead of 20,000 Americans
with CFS/ME, the number is
probably closer to a million,
according to DePaul’s Center
for Community Research.

that—and then their functioning goes down considerably. Their
parents and school officials often think, ‘Is this child just malingering?’
Unless there is an ally to help the child, the child could easily get
stigmatized for this condition,” says Jason.
In another prospective longitudinal study, Ben Katz, a professor
of pediatrics at Northwestern’s Feinberg School of Medicine, is
partnering with Jason to look at the link between mononucleosis,
which is triggered by the Epstein-Barr virus, and CFS/ME in youth.
The study looks at which percentage of those who develop mono
will go on to develop CFS/ME and why. “About 5 percent of all kids
who go to college will get mono before they graduate, and about 12
percent who get mono will meet criteria for CFS/ME six months
later,” says Katz. “Why do most people recover? Nobody knows the
answer, and that’s why we decided to study college kids. By enrolling
people when they’re healthy, you can see if they get mono and why
some recover and some don’t.”
Data collection to estimate the prevalence of CFS/ME among youth
will be completed in 2019, and soon after, papers will be submitted
for publication, according to Jason. The results of the mono-CFS/
ME study will also be released in 2019.
“This is an exciting study as we are getting close to finding out
some kind of answers,” adds Katz.

On the Brink of a Breakthrough
Answers are exactly what people like Fero need. “I am almost 69,
and I’ve had this for more than half my life,” she says. She’s buoyed,
however, by a changing tide of events, from an emboldened sense of
advocacy among patients through the power of social media to the
growing number of institutions working to find some answers. Stanford
University, for example, has created both an initiative to study CFS/
ME and a CFS research center under the direction of Ronald Davis,
a professor of biochemistry and genetics whose son has a severe case
of the disease.
“Are we getting closer to a breakthrough?” Jason asks. “I think
so, yes.”

In the second half of the 19th century,
a new epidemic spread across the
country: Women of the upper and
middle classes were taking to their
beds with fatigue and weakness. It
was neurologist George Miller Beard
who gave this condition a name:
neurasthenia. He blamed the malady
on the modern predicament of
“American nervousness.”
Despite a rash of outbreaks
reported around the world beginning
in the 1930s, it wasn’t until a 1955
outbreak in London that this mystery
disease was given a more scientific
diagnosis: myalgic encephalomyelitis
(ME), which means inflammation of
the brain.
But the Centers for Disease Control
and Prevention (CDC) reversed all
that in 1984 after yet another outbreak in Lake Tahoe, Nev., when they
dubbed the condition chronic fatigue
syndrome (CFS).
“When we gave medical interns the
name ‘chronic fatigue syndrome’ with
a prototypical person with this illness
versus a medical sounding term
(myalgic encephalopathy), we found
there was judgment when they saw
‘chronic fatigue’ because it seemed
psychological. If you called something
chronic cough syndrome, they’d say,
‘So what? Everyone coughs.’ But if
you called it bronchitis or emphysema, then people would say, ‘This is
important,’” says DePaul Psychology
Professor Leonard Jason, who is a
leading authority on CFS/ME.
That’s why so many patients prefer
the term myalgic encephalomyelitis.
“It’s a brain infection,” says Marcie
Zinn, a psychologist who conducted CFS/ME research at the DePaul
Center for Community Research. “So
many people still think the disease is
in your head, so the diagnosis really
needs to be more clinical; otherwise
people with the disease are left
fighting two battles: the disease itself
and public perception.”
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